Essylimar 0.1g is recommended for adjunctive use in people suffering from onerous symptoms associated with hepatic impairment. Each tablet contains 100mg of silymarin-phospholipid complex.
Composition Essylimar 0.1g:
Active substance: silymarin-phospholipid complex. One tablet contains: 100mg of silymarin-phospholipid complex with 30% flavonolignan content expressed as silybin and 1.5% phosphorus and auxiliary substances: microcrystalline cellulose with colloidal silica 2%, croscarmellose sodium, hypromellose, macrogol 6000, titanium dioxide, indigo lacquer E 132), quinoline yellow lake (E 104).
Essylimar action 0.1g:
The unique silymarin-phospholipid complex containing 30% flavonoligans expressed as silybin has a soothing effect on the liver. The indication for the use of Essylimar 0.1g is liver impairment. The effectiveness of the preparation is based only on a long period of use.
Essylimar 0.1g is indicated as adjunctive use in liver dysfunction.
Essylimar Additional information: The product should be kept out of reach of children at room temperature. Use in adolescents between 12 and 18 years old should consult a doctor. If you develop symptoms of jaundice, be sure to consult your doctor.
Do not use in case of hypersensitivity to any component of the drug. It is not recommended to use during pregnancy and lactation. Do not use on children under 12 years of age.
Gastrointestinal disorders may occur when using the drug. There have been sporadic cases of mild laxative effects.
Dosage of Essylimar 0.1g tablets:
It is recommended to use according to the directions on the leaflet or as directed by a doctor. For adults: it is recommended to use one tablet three times a day for chronic diseases, and two tablets three times a day for acute conditions. The tablets should be taken after eating.